May 17, 2024
Safety
New
Revisions of PRECAUTIONS: Pembrolizumab (genetical recombination) posted
May 17, 2024
Safety
New
PMDA Risk Communication: Carglumic acid, etc. posted
May 16, 2024
RS
New
Recent Publications by PMDA Staff updated
May 7, 2024
Safety
PMDA Alert for Proper Use of Drugs: Dependence Associated with Benzodiazepine Receptor Agonists, revised and posted
May 7, 2024
Review
List of Approved Products: FY2023 (April 2023 to December 2023)
May 7, 2024
Int
ICMRA COVID-19 Virus Variants Workshop held in February 2024 posted
May 17, 2024
Drug
IVD
New
Revisions of PRECAUTIONS: Pembrolizumab (genetical recombination) posted
May 17, 2024
Drug
IVD
New
PMDA Risk Communication: Carglumic acid, etc. posted
May 7, 2024
Drug
Devices
Regen.
PMDA Alert for Proper Use of Drugs: Dependence Associated with Benzodiazepine Receptor Agonists, revised and posted
Currently, there is no applicable information.